AU2003237598A1 - Process for the preparation of highly pure rabeprazole sodium salt - Google Patents

Process for the preparation of highly pure rabeprazole sodium salt

Info

Publication number
AU2003237598A1
AU2003237598A1 AU2003237598A AU2003237598A AU2003237598A1 AU 2003237598 A1 AU2003237598 A1 AU 2003237598A1 AU 2003237598 A AU2003237598 A AU 2003237598A AU 2003237598 A AU2003237598 A AU 2003237598A AU 2003237598 A1 AU2003237598 A1 AU 2003237598A1
Authority
AU
Australia
Prior art keywords
preparation
sodium salt
highly pure
rabeprazole sodium
pure rabeprazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003237598A
Other versions
AU2003237598A8 (en
Inventor
Sivakumaran Meenakshisunderam
Dandala Ramesh
K. Ray U.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurobindo Pharma Ltd
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Publication of AU2003237598A8 publication Critical patent/AU2003237598A8/en
Publication of AU2003237598A1 publication Critical patent/AU2003237598A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
AU2003237598A 2002-06-03 2003-06-02 Process for the preparation of highly pure rabeprazole sodium salt Abandoned AU2003237598A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN419CH2002 2002-06-03
IN419/MAS/2002 2002-06-03
PCT/IN2003/000208 WO2003101452A1 (en) 2002-06-03 2003-06-02 Process for the preparation of highly pure rabeprazole sodium salt

Publications (2)

Publication Number Publication Date
AU2003237598A8 AU2003237598A8 (en) 2003-12-19
AU2003237598A1 true AU2003237598A1 (en) 2003-12-19

Family

ID=29596801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003237598A Abandoned AU2003237598A1 (en) 2002-06-03 2003-06-02 Process for the preparation of highly pure rabeprazole sodium salt

Country Status (2)

Country Link
AU (1) AU2003237598A1 (en)
WO (1) WO2003101452A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404856B8 (en) * 2003-08-18 2008-03-13 Cadila Pharm Ltd Stable pharmaceutical composition of rabeprazole
US7557217B2 (en) 2004-06-30 2009-07-07 Eisai R&D Management Co., Ltd. Process for production of benzimidazole derivative salt precipitate
ITMI20042437A1 (en) * 2004-12-21 2005-03-21 Dipharma Spa CRYSTALLINE FORM OF RABEPRAZOLO SODICO
ITMI20062449A1 (en) 2006-12-19 2008-06-20 Dipharma Spa CRYSTALLINE FORM OF RABEPRAZOLO SODICO
US8247568B2 (en) 2007-06-21 2012-08-21 Matrix Laboratories Ltd Process for the preparation of pure rabeprazole
WO2011004281A1 (en) 2009-07-09 2011-01-13 Alembic Limited A process for the preparation of amorphous form of rabeprazole sodium
CN102949354B (en) * 2012-11-01 2014-02-26 江苏奥赛康药业股份有限公司 Sodium rabeprazole composition for injection
WO2014091450A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Process for the preparation of rabeprazole
CN104119315B (en) * 2014-05-21 2016-03-02 丽珠医药集团股份有限公司 A kind of preparation method of Sodium rabeprazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2166269B1 (en) * 1999-07-14 2003-04-01 Sint Quimica Sa NEW PROCEDURE FOR OBTAINING DERIVATIVES OF 2- (2-PIRIDINILMETILSULFINIL) -1H-BENZIMIDAZOL.
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections

Also Published As

Publication number Publication date
WO2003101452A1 (en) 2003-12-11
AU2003237598A8 (en) 2003-12-19
WO2003101452A8 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
IL216449A0 (en) Process for the preparation of tetrazole derivatives
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2002307805A1 (en) Process for the preparation of cefdinir
AU2003237598A1 (en) Process for the preparation of highly pure rabeprazole sodium salt
AU2003224781A1 (en) Crystalline forms of rabeprazole sodium
AU2003298178A1 (en) Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
AU2003208595A1 (en) Process for the preparation of pure silica
AU2002367896A1 (en) Process for the preparation of ceftiofur acid
AU2003235951A1 (en) Process for the preparation of 2-aminopyrazine derivatives
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
EP1547993A4 (en) Process for preparation of spirofluorenols
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
EP1646640A4 (en) Method for the preparation of highly pure 1-androstene derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2002338953A1 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
AU2003260813A1 (en) Improved process for preparation of thiazolidinedione derivatives
AU2003278420A1 (en) Process for the preparation of ganciclovir
AU2003219507A1 (en) Process for the preparation of highly pure torsemide
AU2003256006A1 (en) Improved process for preparation of risperidone
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
AU2002344083A1 (en) Process for preparation of voglibose
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003293693A1 (en) Process for the preparation of bisphenols
IL161897A0 (en) Process for the preparation of cephalexin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase